2-52187585-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000440698.1(NRXN1-DT):​n.880-128647A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 152,130 control chromosomes in the GnomAD database, including 3,502 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 3502 hom., cov: 32)

Consequence

NRXN1-DT
ENST00000440698.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.539

Publications

3 publications found
Variant links:
Genes affected
NRXN1-DT (HGNC:52686): (NRXN1 divergent transcript)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000440698.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.449 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000440698.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1-DT
NR_135237.1
n.880-128647A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1-DT
ENST00000440698.1
TSL:2
n.880-128647A>G
intron
N/A
ENSG00000302235
ENST00000785119.1
n.288+693T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.146
AC:
22132
AN:
152012
Hom.:
3484
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.360
Gnomad AMI
AF:
0.0220
Gnomad AMR
AF:
0.0781
Gnomad ASJ
AF:
0.0366
Gnomad EAS
AF:
0.465
Gnomad SAS
AF:
0.181
Gnomad FIN
AF:
0.0414
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0282
Gnomad OTH
AF:
0.126
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.146
AC:
22206
AN:
152130
Hom.:
3502
Cov.:
32
AF XY:
0.148
AC XY:
10998
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.360
AC:
14925
AN:
41462
American (AMR)
AF:
0.0781
AC:
1193
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0366
AC:
127
AN:
3470
East Asian (EAS)
AF:
0.465
AC:
2399
AN:
5160
South Asian (SAS)
AF:
0.181
AC:
874
AN:
4822
European-Finnish (FIN)
AF:
0.0414
AC:
440
AN:
10620
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0282
AC:
1920
AN:
68008
Other (OTH)
AF:
0.134
AC:
282
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
809
1618
2426
3235
4044
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0601
Hom.:
475
Bravo
AF:
0.160
Asia WGS
AF:
0.345
AC:
1199
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
5.6
DANN
Benign
0.90
PhyloP100
0.54

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1922197;
hg19: chr2-52414723;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.